Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 6/20 | 0.60 |
| ▸ | ANPEP | P15144 | 5/20 | 0.60 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.52 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.52 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | DHFR | P00374 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20110421 | 0.82 | DPP4 (0.55) | DPP4ANPEPNR1H2NR1H3POLB | |
| SCHEMBL6925321 | 0.79 | ANPEP (0.66) | DPP4ANPEPNR1H2NR1H3POLB | |
| SCHEMBL29366407 | 0.78 | DPP4 (0.78) | DPP4ANPEPNR1H2NR1H3POLB | |
| SCHEMBL2820118 | 0.78 | DPP4 (0.78) | DPP4ANPEPNR1H2NR1H3POLB | |
| SCHEMBL1517946 | 0.78 | DPP4 (0.54) | DPP4ANPEPNR1H2NR1H3 | |
| SCHEMBL1679993 | 0.78 | ANPEP (0.53) | DPP4ANPEPNR1H2NR1H3MEN1 | |
| SCHEMBL17531021 | 0.77 | ANPEP (0.67) | DPP4ANPEPNR1H2NR1H3POLB | |
| SCHEMBL30954668 | 0.77 | ANPEP (0.67) | DPP4ANPEPNR1H2NR1H3POLB | |
| SCHEMBL11018078 | 0.77 | DPP4 (0.71) | DPP4ANPEPNR1H2NR1H3 | |
| SCHEMBL11016604 | 0.77 | DPP4 (0.71) | DPP4ANPEPNR1H2NR1H3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8501948-B2 | Multiple chromophores based on rylene | BASF AKTIENGESELLSCHAFT (DE) | 2013-08-06 | — | — | US | disclosed |
| US-20120138125-A1 | FLUORESCENT SOLAR CONVERSION CELLS BASED ON FLUORESCENT TERYLENE DYES | BASF SE (DE) | 2012-06-07 | — | — | US | disclosed |
| EP-1501897-B1 | METHOD FOR THE PRODUCTION OF PERYLEN-3,4:9,10-TETRACARBOXYLIC ACID DIIMIDES AND PERYLEN-3,4:9,10-TETRACARBOXYLIC ACID DIANHYDRIDE AND NAPHTALENE-1,8-DICARBOXYLIMIDES | BASF SE (DE) | 2012-03-14 | — | — | EP | disclosed |
| US-7807836-B2 | Preparation of perylen-3,4:9,10-tetracarboxylic dianhydride and also of naphtalene-1,8-dicarboximides | BASF AKTIENGESELLSCHAFT (DE) | 2010-10-05 | — | — | US | disclosed |
| US-20080287678-A1 | Multiple Chromophores Based on Rylene | BASF AKTIENGESELLSCHAFT (DE) | 2008-11-20 | — | — | US | disclosed |
| US-20080245411-A1 | Fluorescent Solar Conversion Cells Based on Fluorescent Terylene Dyes | BASF SE | 2008-10-09 | — | — | US | disclosed |
| US-20080161569-A1 | PREPARATION OF PERYLEN-3,4:9,10-TETRACARBOXYLIC DIANHYDRIDE AND ALSO OF NAPHTALENE-1,8-DICARBOXIMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2008-07-03 | — | — | US | disclosed |
| US-7393956-B2 | Method for the production of perylen-3,4:9,10-tetracarboxylic acid diimides and perylen-3,4:9,10-tetracarboxylic acid dianhydride and naphtalene-1,8-dicarboxylimides | BASF AKTIENGESELLSCHAFT (DE) | 2008-07-01 | — | — | US | disclosed |
| US-20050131220-A1 | Method for the production of perylen-3,4:9,10-tetracarboxylic acid diimides and perylen-3,4:9,10-tetracarboxylic acid dianhydride and naphtalene-1,8-dicarboxylimides | BASF AKTIENGESELLSCHAFT (DE) | 2005-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080161569-A1 | PREPARATION OF PERYLEN-3,4:9,10-TETRACARBOXYLIC DIANHYDRIDE AND ALSO OF NAPHTALENE-1,8-DICARBOXIMIDES | CLIC1, PNPO, CLIC4 | DPP4 4115/4885ANPEP 946/4885NR1H2 1922/4885 |
| US-20050131220-A1 | Method for the production of perylen-3,4:9,10-tetracarboxylic acid diimides and perylen-3,4:9,10-tetracarboxylic acid dianhydride and naphtalene-1,8-dicarboxylimides | CBR1, CBR3, SCO2 | DPP4 4749/4885ANPEP 3435/4885NR1H2 267/4885 |
| US-20080287678-A1 | Multiple Chromophores Based on Rylene | TDO2, PPOX, NPY1R | DPP4 3749/4885ANPEP 2170/4885NR1H2 186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.